Item 2(b) of the Schedule 13D is hereby amended and supplemented by adding the following information: "The information set forth in Exhibit 99.24 is incorporated by reference into this Item 2(b) as if restated in full."

Item 2(c) of the Schedule 13D is hereby amended and supplemented by adding the following information: "The information set forth in Exhibit 99.24 is incorporated by reference into this Item 2(c) as if restated in full."

Item 3 of the Schedule 13D is hereby amended and supplemented by adding the following information: "The information set forth in Item 4 of Amendment No. 23 is incorporated by reference into this Item 3 as if restated in full."

Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following information: "After productive discussions with the Special Committee of independent directors of the Board of Directors of the Issuer, including a meeting on February 13, 2025, PS Holdco has determined to withdraw its previously disclosed non-binding Proposal of January 13, 2025 in order to put forward an improved non-binding proposal (the "New Proposal"), as further discussed below. Under the New Proposal, PS Holdco would invest $900 million in a primary purchase of Common Stock of the Issuer at a price of $90 per share, which represents a 46.4% premium to the $61.46 unaffected price of the Common Stock on August 5, 2024 (i.e., the closing price on August 5, 2024 prior to the Reporting Persons' August 6, 2024 amendment of its Schedule 13D announcing its intention to evaluate a potential transaction with the Issuer including possibly a going private transaction). The investment is expected to be funded by existing cash on PS Holdco's balance sheet and will not require any financing. The shares of Common Stock acquired by PS Holdco would be in addition to the Reporting Persons' and Pershing Square Funds' current beneficial ownership of the Common Stock reported in the Schedule 13D. After giving effect to the $900 million investment, the Reporting Persons' beneficial ownership would increase from 37.6% to 48.0%. PS Holdco would have certain protective rights in light of its status as a minority shareholder with significant economic exposure to the Issuer. These protections would include anti-dilution provisions as well as limited consent rights, such as in the case of amendments to the Issuer's constituent documents, significant incurrences of indebtedness, significant acquisitions or dispositions, merger or dissolution of the Issuer, and other fundamental corporate events, including director nomination rights. Under the New Proposal, the Issuer will become a diversified holding company that pursues the acquisition of controlling interests in public and private companies. The Issuer will have PS Holdco and its affiliates' full resources available to it. In consideration for the services rendered, PS Holdco will receive a fee of 1.5% per annum of the equity market capitalization of the Issuer. The Reporting Persons are also prepared to subject the New Proposal to the prior approval of the Special Committee. No assurances can be given regarding the terms and details of any potential transaction, that the New Proposal or any other proposal made by the Reporting Persons regarding any potential transaction will be accepted by the Issuer or its Special Committee, that definitive documents relating to any such potential transaction will be executed, or that a potential transaction will be consummated in accordance with such documents, if at all. Attached as Exhibit 99.23 to the Schedule 13D are excerpts of materials (the "Excerpts of Special Committee Presentation") used by representatives of PS Holdco, in its February 13, 2025 meeting with the Issuer's Special Committee, subject to non-substantive presentation changes for purposes of public disclosure. Slides 1-14 of the Excerpts of Special Committee Presentation which describe the New Proposal are incorporated herein by reference. The foregoing description of the New Proposal is not necessarily complete and is qualified in its entirety by reference to the incorporated Excerpts of Special Committee Presentation. Neither the Schedule 13D nor the New Proposal is an offer to purchase or a solicitation of an offer to sell any securities. Any solicitation or offer will only be made through separate materials filed with the U.S. Securities and Exchange Commission. Holders of Common Stock of the Issuer and other interested parties are urged to read these materials when and if they become available because they will contain important information. Holders of Common Stock of the Issuer will be able to obtain such documents (when and if available) free of charge at the Commission's web site, www.sec.gov. The Reporting Persons reserve the right to modify or withdraw the New Proposal at any time. While the New Proposal remains under consideration by the Issuer, the Reporting Persons expect to respond to inquiries from, and negotiate the terms of the New Proposal with, the Special Committee of the Issuer's Board of Directors formed to evaluate the New Proposal and such Special Committee's representatives. The Reporting Persons may elect not to update or provide additional disclosures regarding the New Proposal until a definitive agreement has been reached, or unless disclosure is otherwise required under applicable securities laws."

Item 6 of the Schedule 13D is hereby amended and supplemented by adding the following information: "The information set forth in Item 4 of Amendment No. 23 is incorporated by reference into this Item 6 as if restated in full."

Item 7 of the Schedule 13D is hereby amended and supplemented by adding a reference to the following exhibits: Exhibit 99.23 Excerpts of Special Committee Presentation, delivered February 13, 2025 by PS Holdco to the Special Committee of the Board of Directors of the Issuer. Exhibit 99.24 Members of PS Holdco GP Managing Member, LLC